Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Silo Pharma Inc
(OP:
SILO
)
N/A
UNCHANGED
Last Price
Updated: 3:23 PM EDT, Sep 14, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silo Pharma Inc
< Previous
1
2
3
4
Next >
Silo Pharma Inc. (SILO) Produced Initial Liposome Batch for Rheumatoid Arthritis Study
July 25, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO), UMB Collaborating on Potentially Significant Homing-Peptide Technology
July 22, 2022
Via
Investor Brand Network
Study Says Ayahuasca Users Tend to Exercise More, Eat Healthier
July 21, 2022
Via
Investor Brand Network
Topics
Religion
Exposures
Religion
Study Finds That Microdosing Psilocybin Mushrooms Improves Mood, Mental Health
July 15, 2022
Via
Investor Brand Network
Homing Peptides: Silo Pharma Inc. (SILO) Targets ADRs
July 13, 2022
Via
Investor Brand Network
Silo Pharma Inc. (SILO) Takes Aim at Alzheimer’s Disease
June 27, 2022
Via
Investor Brand Network
Study Suggests COVID-19 Increases Parkinson’s Disease Risk
May 27, 2022
Via
Investor Brand Network
Exposures
COVID-19
New Research Suggests Mental Disorders Magnify Dementia Risk
May 23, 2022
Via
Investor Brand Network
Study Maps How Brain Changes During Treatment for Depression
July 14, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Announces Positive Results of New Study
July 12, 2022
Via
Investor Brand Network
DEA Sets Hearing Date Regarding Plan to Ban Several Psychedelics
July 12, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Bringing Hope, Possible Therapeutic to Alzheimer’s Patients
July 08, 2022
Via
Investor Brand Network
Federal Health Agencies Admit That Classification of Psychedelics Is Impeding Research
July 07, 2022
Via
Investor Brand Network
Brain Cell Regulation Mechanism Could Unlock Novel Treatment Modalities for Neurological Conditions
July 06, 2022
Via
Investor Brand Network
New Report Says Smoking Amplifies Schizophrenia and Depression Risk
June 28, 2022
Via
Investor Brand Network
What Investors Interested in Psychedelics Need to Focus on Regarding IP Issues
June 27, 2022
Via
Investor Brand Network
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Announces Expansion of License Agreement and Patent Portfolio
June 23, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Study Finds Frequent Nightmares May Be Sign of Parkinson’s Disease Development
June 22, 2022
Via
Investor Brand Network
New Study Finds Dose Tapering May Heighten Risk of Opioid Overdoses
June 21, 2022
Via
Investor Brand Network
Mystical Experiences Due to Psilocybin Linked to Positive Mental Well-Being
June 16, 2022
Via
Investor Brand Network
Study Says Damage to Neurons, Not Plaque Triggers Alzheimer’s Onset
June 14, 2022
Via
Investor Brand Network
Topics
Death
Exposures
Death
Five Books on Psychedelics You May Enjoy Reading
June 13, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Committed to Psilocybin, Anti-Inflammatory Research
June 13, 2022
Via
Investor Brand Network
Study Offers New Insights into Psilocybin’s Mechanism for Treating Depression
June 08, 2022
Via
Investor Brand Network
At least 4 in 10 Long-COVID Patients Report Symptoms Akin to Fibromyalgia
June 07, 2022
Via
Investor Brand Network
Exposures
COVID-19
UK Firm Develops Inhaler to Facilitate Psychedelic Microdosing
June 03, 2022
Via
Investor Brand Network
UC Davis Awarded Grant to Find New Non-hallucinogenic Psychedelic Treatments for Addiction
May 31, 2022
Via
Investor Brand Network
Silo Pharma Inc. (SILO) Focuses on Psilocybin’s Anti-Inflammatory Properties
May 31, 2022
Via
Investor Brand Network
Davos Hosts Psychedelic Medical Series
May 25, 2022
Via
Investor Brand Network
Exposures
COVID-19
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Bringing Hope to Patients Suffering from Alzheimer’s and Potentially Other Ailments
May 23, 2022
Via
Investor Brand Network
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.